Chapter 98 Acute respiratory failure in children
Established or imminent respiratory failure is the commonest reason for admission to neonatal and paediatric intensive care units (ICUs). A number of structural and functional factors contribute to the high incidence of respiratory failure, particularly in the first year of life. In addition, respiratory failure is frequently a consequence of pathology primarily affecting other organ systems, e.g. congenital heart disease or central nervous system (CNS) disease.
PREDISPOSING FACTORS
STRUCTURAL IMMATURITY OF THE THORACIC CAGE1
In the neonate, the diaphragm and intercostal muscles have a lower percentage of type 1 (slow twitch and high oxidative) muscle fibres and therefore fatigue more readily. Diaphragmatic muscle mass is relatively reduced. Intercostal muscle activity is inhibited during rapid eye movement sleep, further reducing ventilatory efficiency. Increased respiratory work is poorly sustained in the face of increased load and may culminate in exhaustion and apnoea.2
INCREASED SUSCEPTIBILITY TO INFECTION
The immaturity and inexperience of the immune system (cellular and humoral) result in a markedly increased susceptibility to infection in the first 6 months of life. The neonate’s T-cells are unable to produce certain cytokines which compromises the interaction between T-cells and B-cells. There is greater reactivity of T-suppressor cells to T-helper cells. Complement activation is impaired in premature and full-term neonates. The neonate’s phagocytes have diminished motility, adherence and chemotaxis but bacterial killing by polymorphonuclear leukocytes is intact. In addition, there are many immune deficiency syndromes that may first reveal themselves early in postnatal life.
AETIOLOGY
Acute respiratory failure may result from upper or lower airway obstruction, alveolar disease, pulmonary compression, neuromuscular disease or injury (Table 98.1). Upper respiratory tract obstruction is discussed in Chapter 97.
Site | Neonate | Older infant and child |
---|---|---|
Upper airway obstruction | ||
See Chapter 103 | ||
Lower airway obstruction | ||
Tracheal | Tracheomalacia | Foreign body |
Vascular anomalies | ||
Tracheal stenosis | Mediastinal tumour | |
Bronchial | Bronchomalacia | Foreign body |
Bronchiolar | Meconium aspiration | |
Congenital cystic adenomatoid malformation | Acute viral bronchiolitis | |
Lobar emphysema | ||
Disorders of lung function | ||
Aspiration syndromes | Pneumonia | |
Cystic fibrosis | ||
Hyaline membrane disease | ||
Bronchopulmonary dysplasia | Aspiration syndromes | |
Perinatal pneumonia | ||
Massive pulmonary haemorrhage | Congenital heart disease | |
Pulmonary oedema | Near-drowning | |
Pulmonary hypoplasia | Trauma | |
Diaphragmatic hernia | Burns | |
Acute respiratory distress syndrome | ||
Pulmonary compression | ||
Diaphragmatic hernia | Pneumothorax | |
Pneumothorax | Pleural effusion | |
Repaired exomphalos or gastroschisis | Empyema | |
Neurological and muscular disorders | ||
Diaphragmatic palsy | Poisoning | |
Birth asphyxia | Meningitis | |
Convulsions | Encephalitis | |
Apnoea of prematurity | Status epilepticus | |
Trauma | ||
Guillain–Barré syndrome | ||
Envenomation |
TRACHEOMALACIA, TRACHEAL STENOSIS AND VASCULAR COMPRESSION
Division of the vascular ring and ligation or repositioning of the aberrant vessel, while removing the cause of the obstruction, do not immediately re-establish normal airway dimensions or stability. Although severity of symptoms may be alleviated by surgery, problems may persist for some years. Tracheomalacia may sometimes be stabilised by a prolonged period of nasotracheal intubation or tracheostomy with continuous positive airway pressure (CPAP). Tracheopexy, which suspends the anterior tracheal wall from the posterior sternal surface and great vessels, is occasionally useful. A slide tracheoplasty may be required to correct tracheal stenosis associated with complete tracheal rings.3 A range of stenting devices have also been developed for complex airways and employed with mixed success.
MECONIUM ASPIRATION SYNDROME
Most of these infants require oxygen therapy. Severely affected infants require controlled mechanical ventilation (CMV), which may be difficult because of the high pressures required, the non-uniformity of ventilation, and danger of pneumothorax. Improved outcomes are now achieved using surfactant (may cause transient deterioration), inhaled nitric oxide and high-frequency oscillation.4 Extracorporeal membrane oxygenation (ECMO) is also effective in those centres that have the facility, although its use has declined since the introduction of the above therapies. Cerebral effects of severe intrapartum asphyxia contribute to overall morbidity and mortality.
HYALINE MEMBRANE DISEASE
Clinical signs appear shortly after birth and consist of tachypnoea, chest-wall retraction, expiratory grunting and a progressive increase in oxygen requirements. The chest X-ray reveals a reticulogranular pattern (ground-glass appearance) with air bronchograms. In uncomplicated cases, the disease is self-limiting and resolves in 4–5 days. Respiratory failure may require increasing inspired oxygen concentrations (FiO2), CPAP, intermittent mandatory ventilation (IMV) or CMV. CPAP is known to improve oxygenation, the pattern and regularity of respiration, retard the progression of the disease and reduce morbidity, particularly with early application in the extremely preterm infant. In infants with persistent pulmonary hypertension, transitional circulation and requiring high airway pressures, the use of inhaled nitric oxide and high-frequency oscillatory ventilation are beneficial.
Instillation of surfactant into the trachea has been shown to improve oxygenation and compliance (despite some initial deterioration) and reduce the risk of pneumothorax, early mortality and morbidity.5–8 Two types of surfactant are used: synthetic (Exosurf), and bovine (Survanta) or porcine (Curosurf).
PNEUMONIA
Bacterial pneumonia also occurs. Pneumococcal pneumonia is common and usually responds dramatically to appropriate antibiotic therapy. Staphylococcal pneumonia is relatively uncommon, but may result in life-threatening respiratory failure, and is often associated with complications (e.g. empyema, pneumatocele, tension pneumothorax and suppuration in other organs). Aspiration of an effusion may be useful for diagnostic purposes. Parapneumonic effusions (empyema) may require tube thoracostomy or video-assisted thoracoscopic drainage. Resolution of the effusion can be enhanced by the instillation of thrombolytic agents such as urokinase or tissue plasminogen activator.9 In severe cases with bronchopleural fistula, surgical resection of the necrotic area offers the best chance of survival.
PULMONARY OEDEMA
Pulmonary oedema in the newborn period is due mostly to congenital heart disease, especially coarctation of the aorta, patent ductus arteriosus, critical aortic stenosis and, rarely, obstructed total anomalous pulmonary venous drainage. Pulmonary oedema due to circulatory overload may also occur in erythroblastosis fetalis, the placental transfusion syndrome, or as a result of inappropriate fluid therapy. Myocarditis is a further cause seen throughout infancy and childhood. Prolonged supraventricular tachycardia may result in ventricular dysfunction and biventricular failure, including pulmonary oedema.